How to balance prognostic factors in controlled phase II trials: randomization or minimization ? An analysis of clinical trials in digestive oncology
ANNÉE
2024
AUTEURS
Martin E, Le Malicot K, Guérin-Charbonnel C, Bocquet F, Bouché O, Turpin A, Aparicio T, Legoux JL, Dahan L, Taieb J, Lepage C, Dourthe LM, Pétorin C, Bourgeois V, Raoul JL, Seegers V
CONGRÈS/REVUE
Current Oncology
LIEN PUBLICATIONS ASSOCIÉES